What is OneProjects?
OneProjects is a privately held, venture-backed entity headquartered in Leinster, Ireland, established in 2017. The company operates at the confluence of hardware, software, and data science to design and develop a novel 4D imaging platform specifically for cardiac applications. This advanced technology aims to revolutionize diagnostic capabilities within the cardiovascular field, offering enhanced precision and insights for medical professionals. The company's foundation in 2017 positions it as a growing player in the medtech innovation landscape.
How much funding has OneProjects raised?
OneProjects has raised a total of $29.8M across 4 funding rounds:
Series A
$12.8M
Multiple Rounds
$17M
Series A (2020): $12.8M with participation from Atlantic Bridge University Fund, Enterprise Ireland, and Life Sciences Partners
Grant (2021): $6M led by Disruptive Technologies Innovation Fund
Series A (2021): $8M supported by Summit Bridge Capital, Life Sciences Partners, The European Innovation Council, and Imec.xpand
Grant (2021): $3M featuring EIC Accelerator
Key Investors in OneProjects
Enterprise Ireland
Enterprise Ireland is a government agency dedicated to fostering the growth of Irish businesses in manufacturing and internationally traded services, providing crucial support for innovative companies.
Life Sciences Partners
Life Sciences Partners (LSP) is a prominent European venture capital firm specializing in the life sciences sector, investing in companies with transformative potential from early-stage to growth phases.
Summit Bridge Capital
Summit Bridge Capital is a growth technology fund co-managed by Atlantic Bridge Capital and WestSummit Capital Management, focusing on cross-border technology companies in sectors like internet, software, and cloud.
What's next for OneProjects?
With a substantial total funding of $29.8M and a recent strategic investment of $6M, OneProjects is poised for significant expansion. The company's Series A funding rounds and grants indicate a strong trajectory from early-stage development towards scaling its operations and commercializing its groundbreaking cardiac imaging platform. Future endeavors will likely focus on further refining the technology, expanding clinical trials, securing regulatory approvals, and establishing a robust market presence, potentially signaling a move towards later-stage growth or even pre-IPO preparations.
See full OneProjects company page
